Jane Koo, PhD

Jane Koo, PhD has extensive work experience in the field of regulatory affairs and CMC (Chemistry, Manufacturing, and Controls) within the pharmaceutical industry. Jane is currently working as the Head of Regulatory Affairs at CTMC, a joint venture between Resilience and MD Anderson Cancer Center. Prior to their current role, they served as the Head of Regulatory CMC at MD Anderson Cancer Center.

Before joining MD Anderson, Jane held a position as the Senior Director of Regulatory CMC at Iovance Biotherapeutics, Inc. Jane also worked as the Associate Director of Regulatory Affairs CMC at Allogene Therapeutics and as the Senior Manager of Regulatory Affairs CMC at AbbVie.

Jane's experience in regulatory affairs and CMC began in 2010 when they started working as a Manager in the R&D Divisional Group, CMC at Celltrion Inc. Jane then moved on to Teva Pharmaceuticals where they served as the Manager of Global Regulatory Affairs CMC.

Overall, Jane Koo, PhD has a solid background in regulatory affairs and CMC, with progressively senior roles in multiple organizations within the pharmaceutical industry.

Jane Koo, PhD, completed their Bachelor of Science degree in Biology at North Carolina State University from 2000 to 2004. Jane then pursued their doctoral studies in Biological Sciences at the Korea Advanced Institute of Science and Technology, where they earned their PhD from 2005 to 2010.